The Global Health Body Raises Alert Over Severe Shortage of Weight-Loss Injections

Fewer than one in 10 patients that would benefit from weight-loss injections such as Wegovy can access them, caution the World Health Organization as it issues its initial guidance on the therapies.

Considering in excess of 1,000,000,000 people worldwide now living with obesity, it is calling for more widespread and fairer access to this class of drugs.

Per forecasts, in excess of 2,000,000,000 could be obese by 2030 without intervention.

"The latest guidelines acknowledges that obesity is a long-term condition that can be addressed with thorough and lifelong care," stated the agency's head Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and supply-chain constraints are significant barriers to broad availability to the injections that can aid individuals in losing considerable body mass, says the organization.

Weight-Loss Drug Supply Crisis

Despite the present most optimistic outlook, the supply of GLP-1 therapies could only cover approximately 100 million people – fewer than 10% of those who need them, as stated by the WHO.

The advice calls on countries and companies to widen access, via approaches such as voluntary licensing.

The intellectual property rights on the active ingredient – the primary ingredient of the drug Wegovy – is due to expire in a number of nations in 2026.

How Obesity Drugs Operate

These medications replicate a natural hormone to reduce digestion speed, reduce hunger and enhance feelings of fullness so individuals reduce food intake.

People commonly see weight reduction in the initial weeks of beginning the weekly injections.

Studies indicates users may regain a significant portion within a year of halting the medication, as their usual food cravings come back.

Being overweight or obese raises your risk for contracting health problems, including diabetes, cardiovascular issues, brain attack, and certain cancers.

Excess weight affects people in countries worldwide and was responsible for 3.7 million deaths worldwide in 2024, according to the WHO.

Nicole Gallegos
Nicole Gallegos

Lena Visser is a lifestyle and technology writer with a passion for helping readers make smarter choices.